Pharmacology of Chloroquine + Azirthromycin in Mx of COVID-19

Pharmacology of Chloroquine + Azirthromycin in Mx of COVID-19

A pre-print paper summarised the pharmacology of Hydroxychloroquine and azithromycin as early treatment options in management of COVID-19, safety, toxicity and possible drug-drug interactions information based on available evidence.

The article also briefly describes the possible mechanisms of action of the two drugs, their pharmacokinetics, pharmacological considerations for their combination, cardiac toxicity and other ADR potentials, drug-drug interaction with other concomitant treatments as well as contra-indications, etc.

Full PDF is here, published at the academic website of the Institute: IHU – Méditerranée Infection

An another pre-print paper published by the same institute shows the efficacy of Hydroxychloroquine and Azithromycin combination in in vitro testing demonstrating synergistic effect.

Share Tweet Send
You've successfully subscribed to COVID-19
Great! Next, complete checkout for full access to COVID-19
Welcome back! You've successfully signed in
Success! Your account is fully activated, you now have access to all content.